1. Home
  2. IRT vs ABCL Comparison

IRT vs ABCL Comparison

Compare IRT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independence Realty Trust Inc.

IRT

Independence Realty Trust Inc.

HOLD

Current Price

$16.25

Market Cap

4.0B

Sector

Real Estate

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.52

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRT
ABCL
Founded
2009
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
IRT
ABCL
Price
$16.25
$11.52
Analyst Decision
Buy
Strong Buy
Analyst Count
10
5
Target Price
$20.45
$8.40
AVG Volume (30 Days)
2.1M
9.1M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
4.17%
N/A
EPS Growth
41.18
10.91
EPS
0.01
N/A
Revenue
$657,696,000.00
$75,128,000.00
Revenue This Year
$3.21
N/A
Revenue Next Year
$3.54
$21.85
P/E Ratio
$1,632.00
N/A
Revenue Growth
2.76
160.56
52 Week Low
$14.60
$2.75
52 Week High
$18.19
$12.58

Technical Indicators

Market Signals
Indicator
IRT
ABCL
Relative Strength Index (RSI) 42.69 62.36
Support Level $16.18 $3.39
Resistance Level $16.93 $12.58
Average True Range (ATR) 0.31 0.74
MACD -0.05 -0.15
Stochastic Oscillator 20.10 51.40

Price Performance

Historical Comparison
IRT
ABCL

About IRT Independence Realty Trust Inc.

Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Atlanta, Columbus, Dallas, Denver, Houston, Indianapolis, Nashville, Oklahoma City, Raleigh-Durham, and Tampa. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: